VP, Pharma
Basil Systems, United Kingdom
Sam Kay is a dynamic and forward-thinking regulatory affairs expert who stands at the forefront of driving strategic compliance and innovation within health tech, medical devices, and genomics. With a Master of Pharmacy degree from Kingston University London, Sam's exceptional grasp of global regulatory landscapes and standards has made him a standout figure in the field.
Currently excelling as a VP of Pharma with Basil Systems, Sam leads an organization dedicated to furthering regulatory intelligence and strategy in pharma and med-tech. His leadership was instrumental in pioneering regulatory strategies that harmonized product development with patient care. Prior to this role as principal regulatory consultant at Clarivate, Regulatory Intelligence Lead at Gilead Sciences and a Consultant with PwC, Sam's expertise in building regulatory frameworks and intelligence systems was pivotal to the success of multi-million-dollar ventures across the US, EU, and Asia.
Sam Kay is a powerful advocate for the future of healthcare transformation and regulatory excellence. His deep understanding of therapy areas such as oncology, virology, and gene therapies, combined with his global experience, positions him as an influential voice and invaluable contributor in the regulatory intelligence space
Disclosure information not submitted.
Friday, June 7, 2024
1:45 PM – 2:45 PM EDT